Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

[1]  W. McGuire,et al.  Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumors. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  J. Cairns,et al.  Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer. , 1992, British Journal of Cancer.

[3]  C. Benz,et al.  Activated oncogenes and putative tumor suppressor genes involved in human breast cancers. , 1992, Cancer treatment and research.

[4]  J. Lazo,et al.  Expression of the c-Ha-ras oncogene in mouse NIH 3T3 cells induces resistance to cisplatin. , 1991, Cancer research.

[5]  C. Osborne,et al.  Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen. , 1991, Journal of the National Cancer Institute.

[6]  P. Toy,et al.  A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian tumor cell lines. , 1991, Cancer research.

[7]  A. Ullrich,et al.  p185HER2 signal transduction in breast cancer cells. , 1991, The Journal of biological chemistry.

[8]  M. Kraus,et al.  Oncogenic potential of erbB-2 in human mammary epithelial cells. , 1991, Oncogene.

[9]  A. Ullrich,et al.  Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth. , 1991, Growth regulation.

[10]  T. Perren.  c-erbB-2 oncogene as a prognostic marker in breast cancer. , 1991, British Journal of Cancer.

[11]  C. Macleod,et al.  Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin. , 1990, The Journal of clinical investigation.

[12]  R. Bast,et al.  Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. , 1990, Cancer research.

[13]  S. Howell,et al.  Increased sensitivity to cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoylphorbol 13-acetate. , 1990, The Journal of biological chemistry.

[14]  C. Benz,et al.  Expression of c-myc, c-Ha-ras1, and c-erbB-2 proto-oncogenes in normal and malignant human breast epithelial cells. , 1989, Journal of the National Cancer Institute.

[15]  M. Weber,et al.  Fibroblasts transformed with v-src show enhanced formation of an inositol tetrakisphosphate. , 1989, Science.

[16]  Michael J. Berridge,et al.  Inositol phosphates and cell signalling , 1989, Nature.

[17]  C. Osborne,et al.  Effects of c-myc overexpression on the growth characteristics of MCF-7 human breast cancer cells. , 1989, Oncogene.

[18]  A. Ullrich,et al.  p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor , 1989, Molecular and cellular biology.

[19]  V. Jordan,et al.  Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration. , 1988, Cancer research.

[20]  C. Benz,et al.  Estrogen-induced post-transcriptional modulation of c-myc proto-oncogene expression in human breast cancer cells. , 1988, The Journal of biological chemistry.

[21]  T. Bauknecht,et al.  Occurrence of epidermal growth factor receptors in human adnexal tumors and their prognostic value in advanced ovarian carcinomas. , 1988, Gynecologic oncology.

[22]  C. Osborne,et al.  Human breast cancer in the athymic nude mouse: cytostatic effects of long-term antiestrogen therapy. , 1987, European journal of cancer & clinical oncology.

[23]  P. Seeburg,et al.  Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. , 1985, Science.

[24]  D. Lowy,et al.  Transfection of v-rasH DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity. , 1985, Science.

[25]  A. van der Eb,et al.  A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.